Sulis Therapeutics
sulistx.comLocations
Copenhagen, Denmark · Aarhus, Denmark
industry
Biotechnology
Size
1 - 10 employees
Stage
Other
founded in
2023
Developer a targeted stimulator of interferon genes (STING) inhibitors intended to treat systemic sclerosis and other inflammatory diseases. The company's lead program focuses on potent and selective inhibitors of stimulators of interferon genes (STING), a key protein involved in the immune response, providing patients with new treatment options for debilitating conditions.
Something looks off?Open jobs at Sulis Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.